Francesca Avogadri

2.6k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

Francesca Avogadri is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Francesca Avogadri has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Francesca Avogadri's work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Francesca Avogadri is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Francesca Avogadri collaborates with scholars based in United States, Italy and United Kingdom. Francesca Avogadri's co-authors include María Rescigno, Taha Merghoub, Jedd D. Wolchok, Alan N. Houghton, Marcello Chieppa, Monica Rimoldi, Angelica Sonzogni, Valentina Salucci, Daniel Hirschhorn-Cymerman and Gianluca M. Sampietro and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Francesca Avogadri

21 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells

2005 627 citations Monica Rimoldi, Marcello Chieppa et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesca Avogadri United States	15	1.2k	542	462	284	277	21	2.0k
Kazutomo Suzue Japan	21	1.2k 1.0×	463 0.9×	569 1.2×	274 1.0×	101 0.4×	44	2.4k
Christian Peters Germany	24	1.8k 1.4×	619 1.1×	276 0.6×	122 0.4×	176 0.6×	45	2.3k
Kristen J. Radford Australia	29	2.2k 1.8×	800 1.5×	837 1.8×	139 0.5×	112 0.4×	67	2.9k
Stuart Adams United Kingdom	26	1.0k 0.8×	669 1.2×	1.4k 3.0×	768 2.7×	261 0.9×	65	2.9k
Katie E. Lacy United Kingdom	23	1.3k 1.1×	509 0.9×	556 1.2×	101 0.4×	62 0.2×	46	2.2k
Elizabeth E. Eynon United States	22	1.7k 1.3×	417 0.8×	624 1.4×	499 1.8×	69 0.2×	42	2.6k
Akemi Kosaka Japan	21	1.1k 0.9×	580 1.1×	573 1.2×	110 0.4×	75 0.3×	41	1.6k
Graham R. Leggatt Australia	32	2.4k 1.9×	940 1.7×	866 1.9×	325 1.1×	77 0.3×	97	3.7k
Frank R. Brennan United Kingdom	25	659 0.5×	213 0.4×	660 1.4×	115 0.4×	380 1.4×	54	2.1k
Christine Sedlik France	26	1.8k 1.4×	571 1.1×	660 1.4×	214 0.8×	62 0.2×	46	2.5k

Countries citing papers authored by Francesca Avogadri

Since Specialization

Citations

This map shows the geographic impact of Francesca Avogadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Avogadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Avogadri more than expected).

Fields of papers citing papers by Francesca Avogadri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Avogadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Avogadri. The network helps show where Francesca Avogadri may publish in the future.

Co-authorship network of co-authors of Francesca Avogadri

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Avogadri. A scholar is included among the top collaborators of Francesca Avogadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Avogadri. Francesca Avogadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Abou‐Alfa, Ghassan K., Ivan Borbath, Lipika Goyal, et al.. (2022). PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib versus gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement.. Journal of Clinical Oncology. 40(16_suppl). TPS4171–TPS4171. 7 indexed citations

2.

Lassman, Andrew B., Juan Manuel Sepúlveda-Sánchez, Timothy F. Cloughesy, et al.. (2022). Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Zurich Open Repository and Archive (University of Zurich). 64 indexed citations

3.

Li, Gary, Melanie A. Krook, Sameek Roychowdhury, et al.. (2019). Abstract 2206: Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors. Cancer Research. 79(13_Supplement). 2206–2206. 3 indexed citations

4.

Li, Gary, Melanie A. Krook, Sameek Roychowdhury, et al.. (2019). Abstract 2206: Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors. 2206–2206. 1 indexed citations

5.

Avogadri, Francesca, Sacha Gnjatic, Jodie Tassello, et al.. (2016). Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2. American Journal of Dermatopathology. 38(3). 201–207. 10 indexed citations

6.

Avogadri, Francesca, Roberta Zappasodi, Arvin Yang, et al.. (2014). Combination of Alphavirus Replicon Particle–Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates. Cancer Immunology Research. 2(5). 448–458. 36 indexed citations

7.

Dai, Peihong, Weiyi Wang, Hua Cao, et al.. (2014). Modified Vaccinia Virus Ankara Triggers Type I IFN Production in Murine Conventional Dendritic Cells via a cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway. PLoS Pathogens. 10(4). e1003989–e1003989. 128 indexed citations

8.

Lesokhin, Alexander M., Tobias M. Hohl, Shigehisa Kitano, et al.. (2011). Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment. Cancer Research. 72(4). 876–886. 292 indexed citations

9.

Schaer, David, Yongbiao Li, Taha Merghoub, et al.. (2011). Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope. PLoS ONE. 6(6). e21214–e21214. 12 indexed citations

10.

Dai, Peihong, Hua Cao, Taha Merghoub, et al.. (2011). Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway. Journal of Virology. 85(20). 10814–10825. 37 indexed citations

11.

Dai, Peihong, Hua Cao, Taha Merghoub, et al.. (2011). Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway. Journal of Virology. 85(23). 12835–12835. 1 indexed citations

12.

Avogadri, Francesca, Taha Merghoub, Maureen F. Maughan, et al.. (2010). Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity. PLoS ONE. 5(9). e12670–e12670. 53 indexed citations

13.

Avogadri, Francesca, Jianda Yuan, Arvin Yang, David Schaer, & Jedd D. Wolchok. (2010). Modulation of CTLA-4 and GITR for Cancer Immunotherapy. Current topics in microbiology and immunology. 344. 211–244. 21 indexed citations

14.

Saccheri, Fabiana, Chiara Pozzi, Francesca Avogadri, et al.. (2010). Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity. Science Translational Medicine. 2(44). 44ra57–44ra57. 166 indexed citations

15.

Nakahara, Takeshi, Hiroshi Uchi, Alexander M. Lesokhin, et al.. (2010). Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs. Blood. 115(22). 4384–4392. 109 indexed citations

16.

Hirschhorn-Cymerman, Daniel, Gabrielle Rizzuto, Taha Merghoub, et al.. (2009). OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. The Journal of Experimental Medicine. 206(5). 1103–1116. 169 indexed citations

17.

Avogadri, Francesca, Deepak Mittal, Fabiana Saccheri, et al.. (2008). Intra‐tumoral Salmonella typhimurium induces a systemic anti‐tumor immune response that is directed by low‐dose radiation to treat distal disease. European Journal of Immunology. 38(7). 1937–1947. 37 indexed citations

18.

Rescigno, María, Francesca Avogadri, & Giuseppe Curigliano. (2007). Challenges and prospects of immunotherapy as cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1776(1). 108–123. 59 indexed citations

19.

Avogadri, Francesca, Chiara Martinoli, Liljana Petrovska, et al.. (2005). Cancer Immunotherapy Based on Killing of Salmonella -Infected Tumor Cells. Cancer Research. 65(9). 3920–3927. 144 indexed citations

20.

Rimoldi, Monica, Marcello Chieppa, Valentina Salucci, et al.. (2005). Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunology. 6(5). 507–514. 627 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact